# Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

> **NCT00006799** · PHASE3 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 13 (actual)

## Conditions studied

- Anorexia
- Cachexia
- Head and Neck Cancer
- Quality of Life

## Interventions

- **DRUG:** megestrol acetate
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00006799
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10-01
- **Primary completion:** 2002-09-06
- **Final completion:** 2002-09-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006799, "Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00006799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*